• Mutual Funds
  • Nippon Mutual Fund
  • Nippon India Pharma Fund (Growth)

Formerly Reliance Pharma Gr

Nippon Mutual Fund

Nippon India Pharma Fund (Growth)

EquitySectoral / Thematic - Pharma And Healthcare

435.9995

NAV (Feb 23)

24.1%
5 Year CAGR
Scripbox Opinion
Neutral
Click here for top ranked funds in sectoral / thematic - pharma and healthcare mutual funds.

Sectoral / thematic - pharma and healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).

The pharma benchmark index itself has been a material underperformer over an extended time frame.

Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.

Our analysis of this fundLearn how we rate funds ->

Fund Size

Category Leader

The fund has been a Category Leader on the Fund Size metric

Outperformance Consistency

Neutral

The performance of the fund on a Outperformance Consistency metric has been Neutral

Scripbox Recommended Equity Funds
Want the equity funds that are right for your long term equity investment needs?Learn more
fund-logo
Parag Parikh Flexi Cap Regular Growth
17.1%5Y CAGR
fund-logo
HDFC Large and Mid Cap Fund Growth
12.7%5Y CAGR
fund-logo
PGIM India Midcap Opportunities Fund Regular Growth
15.8%5Y CAGR
fund-logo
Canara Robeco Bluechip Equity Fund Regular Plan Growth
12.4%5Y CAGR

Investment Calculator

Investment Duration5 years

0

Total Investment

0

Wealth Gained

0

Total Corpus Created (₹)

With CAGR of 11.25 % in 5 years

Historical NAV

435.9995

NAV (Feb 23)

Fund Returns

Last 1Y
61.6%
Last 3Y
21.4%
Last 5Y
24.1%
Last 10Y
17.6%
Since Inception
21.1%
6 Month CAGR
24.8%

Scheme Information

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Expense Ratio
1.85
Launched (20y ago)
Jun 05, 2004
AUM in Crores
6891.312
ISIN
INF204K01968
Lock-in
No Lock-in
Benchmark
S&P BSE Healthcare TR INR
SIP Minimum
1000
Lumpsum Min.
5000
Standard Deviation (3yr)
15.5
Standard Deviation (5yr)
18.6
Beta (3yr)
0.96
Beta (5yr)
0.92
Sharpe Ratio (3yr)
0.91
Sharpe Ratio (5yr)
0.909
YTM
0
Fund Managers

Sailesh Raj Bhan

Fund Manager

Kinjal Desai

Fund Manager

Returns Calculator Comparison

of

for

with step up of

AssetReturnsTotal CorpusGainsCAGR
Nippon India Pharma Fund (Growth)70%13,62,153 6,29,54124.1%
EPF70% 9,00,761 1,68,1498.50%
Property70% 8,67,662 1,35,0507.00%
PPF70% 8,69,819 1,37,2077.10%
Bank FD70% 8,46,471 1,13,8596.00%
Gold70% 8,46,471 1,13,8596.00%
Savings Bank70% 8,25,950 93,3385.00%

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

Asset allocation and Holdings

Last updated on 2024-02-23

Top Stock Holdings

sun pharmaceuticals industries ltd

13.5%
13.5%

lupin ltd

8.3%
8.3%

cipla ltd

6.1%
6.1%

apollo hospitals enterprise ltd

6%
6%

dr reddy's laboratories ltd

4.9%
4.9%
See all holdings

Allocation by Sector

healthcare

99.2%
99.2%
See all sectors

Comparison with Equity Funds

Fund NameFund SizeOutperformance Consistency
HDFC Large and Mid Cap Fund (G)
HDFC Large and Mid Cap Fund (G)

₹ 16,033 cr

₹ 13,846 cr

₹ 20,949 cr

₹ 11,823 cr

₹ 9,962 cr

About the AMC

Nippon Life India Asset Management Ltd

Nippon Life India Asset Management Ltd manages assets worth 337,169 crores and was set up on 24 February 1995. It's current offering of mutual fund schemes includes 105 equity,425 debt and 71 hybrid funds.amc-img
022-33031000
customer_care@reliancemutual.com
Fund NameScripbox Opinion
Till Date CAGR

5.3%

6.9%

5.3%

5.7%

5.3%

6.7%

5.3%

6.7%

5.3%

5.7%

Nippon India Pharma Fund (G) Review

Nippon India Pharma Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 21.1% over a period of 19 years. The fund was previously known as Reliance Pharma Gr. The fund is managed by Nippon Life India Asset Management Ltd. The fund managers are Kinjal Desai, Sailesh Raj Bhan.

Nav of Nippon India Pharma Fund (G) as of 2/23/2024 is ₹436.00 with the total AUM as of 2/26/2024 is ₹6891.312. With Scripbox you can compare and check the latest nav for all mutual funds in India. Nippon India Pharma Fund (G) was launched on Jun 05, 2004. The category risk of the fund is Very High Risk.

The minimum SIP amount for Nippon India Pharma Fund (G) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.

Nippon India Pharma Fund (G) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to S&P BSE Healthcare TR INR.

Nippon India Pharma Fund (G) is rated as a 2 fund in Equity and delivered 61.6% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with Nippon India Pharma Fund (G).

Frequently Asked Questions

What is Nippon India Pharma Fund (G)?

Nippon India Pharma Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity scheme predominantly investing across Equity instruments with an investment objective to generate wealth over the long term.

How to invest in Nippon India Pharma Fund (G)?

You can invest in Nippon India Pharma Fund (G) through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?

What is the minimum sip amount of Nippon India Pharma Fund (G)?

The minimum sip amount for Nippon India Pharma Fund (G) is ₹1000. You can invest in multiples of ₹5000.

Is Nippon India Pharma Fund (G) good to invest in?

As per Scripbox experts, Nippon India Pharma Fund (G) is a Neutral fund. You can investNippon India Pharma Fund (G) fund if its investment objective and risk-o-meter matches your investment goals and risk preferences.

What is the expense ratio of the Nippon India Pharma Fund (G)?

The expense ratio of the Nippon India Pharma Fund (G) is 1.85% for regular plan.